Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
DexCom
DXCM
5
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
US Stock MarketDetailed Quotes
OPTN OptiNose
- 9.050
- +0.050+0.56%
Close Apr 10 16:00 ET
91.62MMarket Cap-4.27P/E (TTM)
9.110High8.900Low195.94KVolume8.970Open9.000Pre Close1.77MTurnover2.81%Turnover RatioLossP/E (Static)10.12MShares20.02552wk High-2.27P/B63.14MFloat Cap4.81552wk Low--Dividend TTM6.98MShs Float450.000Historical High--Div YieldTTM2.33%Amplitude4.815Historical Low9.042Avg Price1Lot Size
About OptiNose Company
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
Company Profile
SymbolOPTN
Company NameOptiNose
Listing DateOct 13, 2017
Issue Price16.00
Founded2000
CEODr. Ramy A. Mahmoud, M.D.
MarketNASDAQ
Employees128
Fiscal Year Ends12-31
Address777 Township Line Road,Suite 300
CityYardley
ProvincePennsylvania
CountryUnited States of America
Zip Code19067
Phone1-267-364-3500
Websitehttp://www.optinose.com
Company Executives
- Name
- Position
- Salary
- Dr. Ramy A. Mahmoud, M.D.
- Chief Executive Officer and Director
- 2.41M
- Paul Spence, Jr
- Chief Commercial Officer
- 664.02K
- Michael F. Marino, III,
- Chief Legal Officer and Corporate Secretary
- 1.32M
- Anthony J. Krick
- Vice President, Finance and Chief Accounting Officer
- --
- P. Terence Kohler, Jr
- Chief Financial Officer and Principal Accounting Officer
- --
- R. John Fletcher
- Chairman of the Board
- 120.22K
- Sandra L. Helton
- Independent Director
- 103.42K
- Wilhelmus C. M. Groenhuysen
- Independent Director
- 100.92K
- Tomas J. Heyman
- Independent Director
- 96.88K
- Kyle Dempsey
- Independent Director
- 90.92K
- Dr. Eric Bednarski
- Independent Director
- 88.42K
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now